Background*

Dr. Geraldine A. Henwood, also known as Gerri, Ph.D., has been the Chief Development Officer of Iomab-B at Actinium Pharmaceuticals, Inc. since September 2012. Dr. Henwood has been the Chief Executive Officer of Garnet Biotherapeutics, Inc. since November 2008. She has been the Chief Executive Officer and President of RECRO Pharma, Inc. since 2008. She is a Venture Partner at SCP Vitalife. She is the Founder of Malvern Consulting Group and served as its President from ... 2006 to 2013. She more than 30 years' experience in product commercialization, clinical development and regulatory approval processes. She founded Auxilium Pharmaceuticals Inc., and served as its Chairman of the Board from July 1999 to April 2005, Chief Executive Officer from July 1999 to July 17, 2006, President from July 1999 to May 2004 and Interim President from March 2005 to July 17, 2006. She served as a Consultant at Auxilium Pharmaceuticals Inc. since July 17, 2006. She served as the Chief Executive Officer and President of Theorem Clinical Research, Inc., since April 1994. From 1985 to 1999, she served as the Chief Executive Officer at IBAH, which she founded in 1985. Prior to that, she served as Group Director of Marketing in the International Pharmaceutical Division at Smith Kline & French Laboratories, part of Glaxo SmithKline PLC. From April 1994 to 1999, she served as the President and Chief Executive Officer of Omnicare Clinical Research, Inc. Prior to that, she served in a variety of marketing, senior medical, and regulatory positions at Smith Kline & French Laboratories. She began her career with Smith Kline & French in the Pharmaceutical Marketing Department. She serves as a Director of Antler Science Two Ltd. She has been a Director of RECRO Pharma, Inc. since 2008, Tetraphase Pharmaceuticals, Inc. since April 15, 2015 and Garnet Biotherapeutics Inc since November 2008. She served as a Director of Alkermes plc from September 16, 2011 to March 7, 2015. She served as a Director of Omnicare Clinical Research, Inc. She served as a Director of Auxilium Pharmaceuticals Inc. since July 1999 until 2006. She served as a Director of Genomics Collaborative, Inc. She served as a Director of Theorem Clinical Research, Inc., since July 1992. She served as a Director of MAP Pharmaceuticals, Inc. from June 2004 to March 1, 2013. She serves on the Board of Trustees of LaSalle Academy. Dr. Henwood holds a B.S. in Biology from Neuman College. She also holds a Ph.D.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.